Daniel N Gregoire Net Worth

The estimated Net Worth of Daniel N Gregoire is at least $25.6 Million dollars as of 3 March 2019. Daniel Gregoire owns over 2,757 units of Magellan Health Inc stock worth over $1,784,672 and over the last 20 years Daniel sold MGLN stock worth over $23,863,315.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Daniel Gregoire MGLN stock SEC Form 4 insiders trading

Daniel has made over 31 trades of the Magellan Health Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently Daniel exercised 2,757 units of MGLN stock worth $261,887 on 3 March 2019.

The largest trade Daniel's ever made was selling 35,658 units of Magellan Health Inc stock on 27 September 2017 worth over $3,036,992. On average, Daniel trades about 5,604 units every 49 days since 2005. As of 3 March 2019 Daniel still owns at least 18,788 units of Magellan Health Inc stock.

You can see the complete history of Daniel Gregoire stock trades at the bottom of the page.

What's Daniel Gregoire's mailing address?

Daniel's mailing address filed with the SEC is C/O MAGELLAN HEALTH SERVICES, INC., 6950 COLUMBIA GATEWAY, STE. 400, COLUMBIA, MD, 21046.

Insiders trading at Magellan Health Inc

Over the last 22 years, insiders at Magellan Health Inc have traded over $207,355,721 worth of Magellan Health Inc stock and bought 25,726 units worth $1,508,914 . The most active insiders traders include Peter A Feld, James E Murray, and Mary F Sammons. On average, Magellan Health Inc executives and independent directors trade stock every 15 days with the average trade being worth of $1,340,119. The most recent stock trade was executed by James E Murray on 2 January 2022, trading 3,262 units of MGLN stock currently worth $309,857.

What does Magellan Health Inc do?

Magellan Health, Inc., a Fortune 500 company, is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan Health supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan Health customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators.

Complete history of Daniel Gregoire stock trades at Magellan Health Inc

Magellan Health Inc executives and stock owners

Magellan Health Inc executives and other stock owners filed with the SEC include:

• Kenneth Fasola,
  Chief Executive Officer, Director
• Mostafa Kamal,
  Chief Executive Officer - Magellan Rx Management
• Steven Shulman,
  Independent Chairman of the Board
• Caskie Lewis-Clapper,
  Chief Human Resource Officer
• Peter Feld,
  Independent Director
• G. Scott MacKenzie,
  Independent Director
• Guy Sansone,
  Independent Director
• Leslie Norwalk,
  Independent Director
• Swati Abbott,
  Independent Director
• Joe Bogdan,
  Senior Vice President, Corporate Finance
• Mural Josephson,
  Director
• Christopher Chen,
  Director
• Tim Lacy,
  Chief Growth Officer
• Caroline Carney,
  Chief Medical Officer
• David Haddock,
  General Counsel, Secretary
• David Bourdon,
  Chief Financial Officer
• James Murray,
  President, Chief Operating Officer
• Jay Youell,
  Sr. VP of Sales - Health Plan & Insurance Markets
• John E. Littel,
  Chief External Affairs Officer
• Darren P. Lehrich,
  Chief Investor Relations Officer
• Renie Shapiro Silver,
  SVP - Corp. Fin.
• David Patrick Bourdon,
  Chief Financial Officer
• William J Mcbride,
  Director
• Eran Broshy,
  Director
• Barry M Smith,
  Director
• Perry G Md Fine,
  Director
• Kay Coles James,
  Director
• John O Agwunobi,
  Director
• Jeffrey N West,
  SVP & Controller
• Sanjeev K Srivastava,
  CEO, Magellan Plan Services
• Mary F Sammons,
  Director
• Jonathan N Rubin,
  Chief Financial Officer
• Michael Diament,
  Director
• Daniel N Gregoire,
  General Counsel and Secretary
• Russell C Petrella,
  President, Behavioral Health
• Mark S Demilio,
  CFO
• Raju L Mantena,
  President, ICORE Healthcare
• Robert W Field,
  CEO, Magellan Pharm Solutions
• Michael P Ressner,
  Director
• Tina Blasi,
  CEO, National Imaging Assoc.
• Robert M Leblanc,
  Director
• Management, L.P.Cohen Arthu...,
  
• Kim Marie Mageau,
  President, Magellan Pharm Sols
• Alan Lotvin,
  President, ICore Healthcare
• Management, L.P.Health Cor ...,
  
• Timothy P Nolan,
  President, First Health Servic
• Karen S Lynch,
  President
• Nancy L Johnson,
  Director
• Allen F Wise,
  Director
• Jeff D Emerson,
  Chief Information Officer
• Rene Lerer,
  President and COO
• Eric Reimer,
  Chief Growth Officer
• William D Forrest,
  Director
• Anthony M Kotin,
  Chief Mkting & Strategy Offcr
• Saul Burian,
  Director
• Keith Dixon,
  President, Behavioral Health
• Holdings Lp Onex Partners G...,
  
• Michael Majerik,
  Chief Sales&Marketing Officer
• Matthew Joseph Simas,
  Director
• Robert M Haft,
  Director
• Gadget, L.P.Scepter Holding...,
  
• Megan M Arthur,
  Executive Vice President
• Holdings Lponex Partners Lp...,